News
Media
Conferences
Partners
Publications
Events
CME/CE
Resources
PBM Directory
Subscribe

Spotlight -

Predictions for 2026: Our January 2026 issue|

MHE State of the Industry survey|

AMCP Nexus 2025|

2025 Fall Clinical Dermatology|

Thomas E. Henry III, MBA, RPh, CPh

Articles by Thomas E. Henry III, MBA, RPh, CPh

Drug vials

Four Opportunities to Tap into Biosimilar Cost Savings

ByThomas E. Henry III, MBA, RPh, CPh,Adrianne Spencer, PhD

September 10th 2019

The policies and approaches healthcare leaders should promote.

Latest Updated Articles

Four Opportunities to Tap into Biosimilar Cost Savings
Published: September 10th 2019 | Updated:

Trending on Managed Healthcare Executive

3 takeaways from Cigna’s 2025 earnings call

What exactly is managed care today?

PBM reform. It has finally happened

Express Scripts agrees to reforms in settlement with FTC

PrEP underprescribed in young women despite need